BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8294897)

  • 1. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.
    Lisanby SH; McDonald WM; Massey EW; Doraiswamy PM; Rozear M; Boyko OB; Krishnan KR; Nemeroff C
    J Neural Transm Suppl; 1993; 40():13-21. PubMed ID: 8294897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
    Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intracranial volume in Parkinson's disease.
    Krabbe K; Karlsborg M; Hansen A; Werdelin L; Mehlsen J; Larsson HB; Paulson OB
    J Neurol Sci; 2005 Dec; 239(1):45-52. PubMed ID: 16225890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.
    Bouchard TP; Malykhin N; Martin WR; Hanstock CC; Emery DJ; Fisher NJ; Camicioli RM
    Neurobiol Aging; 2008 Jul; 29(7):1027-39. PubMed ID: 17368653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced volume of the putamen in REM sleep behavior disorder patients.
    Ellmore TM; Hood AJ; Castriotta RJ; Stimming EF; Bick RJ; Schiess MC
    Parkinsonism Relat Disord; 2010 Dec; 16(10):645-9. PubMed ID: 20846895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicaudate index on magnetic resonance imaging: effects of normal aging.
    Doraiswamy PM; Patterson L; Na C; Husain MM; Boyko O; McDonald WM; Krishnan KR
    J Geriatr Psychiatry Neurol; 1994; 7(1):13-7. PubMed ID: 8192824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.
    Ye FQ; Allen PS; Martin WR
    Mov Disord; 1996 May; 11(3):243-9. PubMed ID: 8723139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
    Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
    Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
    Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
    J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    Mov Disord; 2007 Mar; 22(4):578-81. PubMed ID: 17260343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis.
    Nemmi F; Sabatini U; Rascol O; Péran P
    Neurobiol Aging; 2015 Jan; 36(1):424-33. PubMed ID: 25174648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes in the midbrain with aging and Parkinson's disease: an MRI study.
    Sohmiya M; Tanaka M; Aihara Y; Okamoto K
    Neurobiol Aging; 2004 Apr; 25(4):449-53. PubMed ID: 15013565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease.
    Alegret M; Junqué C; Pueyo R; Valldeoriola F; Vendrell P; Tolosa E; Mercader JM
    Neurologia; 2001 Feb; 16(2):63-9. PubMed ID: 11257931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.